Latest Articles
Near-perfect disease control for bispecific in advanced endometrial cancer - msn.com
Near-perfect disease control for bispecific in advanced endometrial cancer msn.com
Published: April 27, 2026, 1:41 a.m.
Case 1: Advanced and Recurrent MMRd Endometrioid Adenocarcinoma of the Uterus - The ASCO Post
Case 1: Advanced and Recurrent MMRd Endometrioid Adenocarcinoma of the Uterus The ASCO Post
Published: April 26, 2026, 9 p.m.
Case 2: Newly Diagnosed Advanced MMRp Endometrioid Adenocarcinoma - The ASCO Post
Case 2: Newly Diagnosed Advanced MMRp Endometrioid Adenocarcinoma The ASCO Post
Published: April 26, 2026, 9 p.m.
From 40 to 500 rules on average throughout life: how social changes have increased the risk of endometriosis in women - Diari ARA
From 40 to 500 rules on average throughout life: how social changes have increased the risk of endometriosis in women Diari ARA
Published: April 26, 2026, 2:01 p.m.
From 40 to 500 rules on average throughout life: how social changes have increased the risk of endometriosis in women - en.ara.cat
From 40 to 500 rules on average throughout life: how social changes have increased the risk of endometriosis in women en.ara.cat
Published: April 26, 2026, 2:01 p.m.
Bindi Irwin details 'indescribable pain' and agony of 'invisible disease' in heartbreaking health update - MSN
Bindi Irwin details 'indescribable pain' and agony of 'invisible disease' in heartbreaking health update MSN
Published: April 26, 2026, 4:19 a.m.
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) - The Joplin Globe
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) The Joplin Globe
Published: April 24, 2026, 10:11 p.m.
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) - Rutland Herald
Aspira Women's Health (OTCQB:AWHL) Enters Key Growth Phase with Molecular Lab Expansion to Accelerate Breakthrough Endometriosis Blood Test ENDOinform(TM) Rutland Herald
Published: April 24, 2026, 10:11 p.m.
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha - Targeting ADC at AACR Annual Meeting 2026 - riauone.com
Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha - Targeting ADC at AACR Annual Meeting 2026 riauone.com
Published: April 24, 2026, 4:01 a.m.
Case 3: Newly Diagnosed Advanced Uterine Papillary Serous Carcinoma - The ASCO Post
Case 3: Newly Diagnosed Advanced Uterine Papillary Serous Carcinoma The ASCO Post
Published: April 23, 2026, 9:09 p.m.
Link copied to clipboard!